To hear about similar clinical trials, please enter your email below
Trial Title:
Exploring Engagement Dynamics Among Individuals Impacted by Bladder Cancer
NCT ID:
NCT06009510
Condition:
Bladder Cancer
Conditions: Official terms:
Urinary Bladder Neoplasms
Conditions: Keywords:
bladder cancer
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Summary:
The study seeks to delve into the firsthand experiences of patients diagnosed with
bladder cancer who partake in a separate clinical trial featuring a specific medical
intervention. The primary emphasis will be on meticulously tracking the rates of trial
completion and withdrawal among these individuals.
By joining this clinical trial, individuals have the unique opportunity to contribute to
the betterment of future bladder cancer patients and play an active role in advancing
medical research.
Criteria for eligibility:
Study pop:
Bladder cancer patients who are actively considering enrolling in an observational
clinical trial, but have not yet completed enrollment and randomization.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Patient has self-identified as planning to enroll in a clinical trial
- Patient has been diagnosed with bladder cancer
- Patient is a minimum of 18 years or older
Exclusion Criteria:
- Patient does not understand, sign, and return consent form
- Inability to perform regular electronic reporting
- Patient is pregnant
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Power Life Sciences
Address:
City:
San Francisco
Zip:
94107
Country:
United States
Contact:
Last name:
Michael B Gill
Phone:
415-900-4227
Email:
https://www.withpower.com/contact-us@withpower.com
Start date:
September 2024
Completion date:
September 2026
Lead sponsor:
Agency:
Power Life Sciences Inc.
Agency class:
Industry
Source:
Power Life Sciences Inc.
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06009510
